Home Self-Testing for HIV to Increase HIV Testing Frequency in Men Who Have Sex With Men (The iTest Study)
Primary Purpose
HIV
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Home HIV self-testing with OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test
Home HIV self-testing with OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test
Sponsored by

About this trial
This is an interventional screening trial for HIV focused on measuring HIV, Home testing, Self-testing, HIV Infections/diagnosis, HIV Infections/prevention and control, AIDS Serodiagnosis, Oral fluids, Homosexuality, Male, Sexually transmitted diseases, Sexual behavior
Eligibility Criteria
Inclusion Criteria:
- Male
- Age ≥18
- Has sex with men
- HIV-negative
- Meets PHSKC HIV/STD Program definition of "high risk"
- Plans to live in Seattle for the next 15 months
Exclusion Criteria:
- Unable to safely and confidentially receive or store a home testing kit
Sites / Locations
- Public Health - Seattle & King County STD Clinic, located at Harborview Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Home Testing
Standard Testing
Arm Description
Outcomes
Primary Outcome Measures
HIV Testing Frequency
Number of HIV tests during follow-up reported by participants at end-of-study visit
Secondary Outcome Measures
Condomless Anal Intercourse With HIV-positive or Unknown Status Partner in Last 3 Months
Bacterial Sexually Transmitted Infections
Includes syphilis, gonorrhea, and chlamydial infection
Number of Male Condomless Anal Intercourse Partners in Last 3 Months
Full Information
NCT ID
NCT01161446
First Posted
July 9, 2010
Last Updated
May 10, 2017
Sponsor
University of Washington
Collaborators
Public Health - Seattle and King County, National Institute of Mental Health (NIMH)
1. Study Identification
Unique Protocol Identification Number
NCT01161446
Brief Title
Home Self-Testing for HIV to Increase HIV Testing Frequency in Men Who Have Sex With Men (The iTest Study)
Official Title
Comparisons of Public Health Screening Methods for Acute and Early HIV Infection: Home Self-Testing for HIV Infection
Study Type
Interventional
2. Study Status
Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
July 2010 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
December 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Washington
Collaborators
Public Health - Seattle and King County, National Institute of Mental Health (NIMH)
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to determine whether the availability of home self-testing for HIV will increase HIV testing frequency among men who have sex with men without negatively impacting their risk for HIV acquisition.
Detailed Description
HIV counseling and testing remains one of the most effective HIV prevention interventions because many individuals newly diagnosed with HIV infection will alter their behaviors to reduce the risk of HIV transmission to others. In the U.S., men who have sex with men (MSM) represent the group with the greatest risk for HIV acquisition despite a high penetrance of testing, in part because their frequent exposures and infrequent testing can result in long intervals between HIV acquisition and diagnosis. Efforts to prevent HIV transmission among MSM must therefore increase the frequency of HIV testing and thereby decrease the time interval that infected individuals are unaware of their status and their potential for transmission. Home self-testing for HIV may increase the frequency of HIV testing, but there are concerns that it may also have negative consequences, including decreased access to risk reduction counseling.
We will randomize 246 MSM at high risk of HIV acquisition either to have access to home self-testing for HIV using the OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test or to standard, clinic-based HIV testing for 15 months to determine the effects of home self-testing availability on HIV testing frequency and markers of risk for HIV acquisition and to assess the acceptability and ease of use of home self-testing. After screening to determine eligibility, study visits will occur at baseline and at 15 months. Both visits will include HIV/STD screening and surveys regarding HIV testing and risk behaviors. During follow-up, participants will be asked to complete brief online surveys after testing for HIV.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV
Keywords
HIV, Home testing, Self-testing, HIV Infections/diagnosis, HIV Infections/prevention and control, AIDS Serodiagnosis, Oral fluids, Homosexuality, Male, Sexually transmitted diseases, Sexual behavior
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
230 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Home Testing
Arm Type
Experimental
Arm Title
Standard Testing
Arm Type
No Intervention
Intervention Type
Behavioral
Intervention Name(s)
Home HIV self-testing with OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test
Intervention Description
Participants in this arm will be given access to home HIV self-testing kits with the OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test for use with oral fluids. They will be trained to use this device to test themselves for HIV and be able to request up to one self-testing kit per month throughout follow-up.
Intervention Type
Device
Intervention Name(s)
Home HIV self-testing with OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test
Intervention Description
The device is the home HIV self-testing kit that includes the OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test for use on oral fluids. The kit itself is not the focus of this trial. As described in the Behavioral Intervention section, the intervention is having access to home self-testing for HIV.
Primary Outcome Measure Information:
Title
HIV Testing Frequency
Description
Number of HIV tests during follow-up reported by participants at end-of-study visit
Time Frame
15 months
Secondary Outcome Measure Information:
Title
Condomless Anal Intercourse With HIV-positive or Unknown Status Partner in Last 3 Months
Time Frame
From 6 to 9 months and 12 to 15 months of follow-up
Title
Bacterial Sexually Transmitted Infections
Description
Includes syphilis, gonorrhea, and chlamydial infection
Time Frame
Assessed at 15 months
Title
Number of Male Condomless Anal Intercourse Partners in Last 3 Months
Time Frame
From 6 to 9 and 12 to 15 months
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Male
Age ≥18
Has sex with men
HIV-negative
Meets PHSKC HIV/STD Program definition of "high risk"
Plans to live in Seattle for the next 15 months
Exclusion Criteria:
Unable to safely and confidentially receive or store a home testing kit
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joanne D Stekler, MD, MPH
Organizational Affiliation
University of Washington
Official's Role
Principal Investigator
Facility Information:
Facility Name
Public Health - Seattle & King County STD Clinic, located at Harborview Medical Center
City
Seattle
State/Province
Washington
ZIP/Postal Code
98104
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
29697595
Citation
Katz DA, Golden MR, Hughes JP, Farquhar C, Stekler JD. HIV Self-Testing Increases HIV Testing Frequency in High-Risk Men Who Have Sex With Men: A Randomized Controlled Trial. J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):505-512. doi: 10.1097/QAI.0000000000001709.
Results Reference
derived
Learn more about this trial
Home Self-Testing for HIV to Increase HIV Testing Frequency in Men Who Have Sex With Men (The iTest Study)
We'll reach out to this number within 24 hrs